These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. RGS4 is a negative regulator of insulin release from pancreatic beta-cells in vitro and in vivo. Ruiz de Azua I; Scarselli M; Rosemond E; Gautam D; Jou W; Gavrilova O; Ebert PJ; Levitt P; Wess J Proc Natl Acad Sci U S A; 2010 Apr; 107(17):7999-8004. PubMed ID: 20385802 [TBL] [Abstract][Full Text] [Related]
4. Minireview: Novel aspects of M3 muscarinic receptor signaling in pancreatic β-cells. Nakajima K; Jain S; Ruiz de Azua I; McMillin SM; Rossi M; Wess J Mol Endocrinol; 2013 Aug; 27(8):1208-16. PubMed ID: 23820900 [TBL] [Abstract][Full Text] [Related]
5. A critical role for beta cell M3 muscarinic acetylcholine receptors in regulating insulin release and blood glucose homeostasis in vivo. Gautam D; Han SJ; Hamdan FF; Jeon J; Li B; Li JH; Cui Y; Mears D; Lu H; Deng C; Heard T; Wess J Cell Metab; 2006 Jun; 3(6):449-61. PubMed ID: 16753580 [TBL] [Abstract][Full Text] [Related]
6. Role of the M3 muscarinic acetylcholine receptor in beta-cell function and glucose homeostasis. Gautam D; Han SJ; Duttaroy A; Mears D; Hamdan FF; Li JH; Cui Y; Jeon J; Wess J Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():158-69. PubMed ID: 17919190 [TBL] [Abstract][Full Text] [Related]
7. Novel insights into the function of β-cell M3 muscarinic acetylcholine receptors: therapeutic implications. Ruiz de Azua I; Gautam D; Guettier JM; Wess J Trends Endocrinol Metab; 2011 Feb; 22(2):74-80. PubMed ID: 21106385 [TBL] [Abstract][Full Text] [Related]
8. Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice. Duttaroy A; Zimliki CL; Gautam D; Cui Y; Mears D; Wess J Diabetes; 2004 Jul; 53(7):1714-20. PubMed ID: 15220195 [TBL] [Abstract][Full Text] [Related]
9. Beta-cell M Zhu L; Rossi M; Doliba NM; Wess J Int Immunopharmacol; 2020 Apr; 81():106267. PubMed ID: 32044662 [TBL] [Abstract][Full Text] [Related]
10. Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor. Weston-Green K; Huang XF; Deng C CNS Drugs; 2013 Dec; 27(12):1069-80. PubMed ID: 24114586 [TBL] [Abstract][Full Text] [Related]
11. CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo. Rossi M; Ruiz de Azua I; Barella LF; Sakamoto W; Zhu L; Cui Y; Lu H; Rebholz H; Matschinsky FM; Doliba NM; Butcher AJ; Tobin AB; Wess J Proc Natl Acad Sci U S A; 2015 Dec; 112(49):E6818-24. PubMed ID: 26598688 [TBL] [Abstract][Full Text] [Related]
13. Effect of hyperglycaemia on muscarinic M3 receptor expression and secretory sensitivity to cholinergic receptor activation in islets. Hauge-Evans AC; Reers C; Kerby A; Franklin Z; Amisten S; King AJ; Hassan Z; Vilches-Flores A; Tippu Z; Persaud SJ; Jones PM Diabetes Obes Metab; 2014 Oct; 16(10):947-56. PubMed ID: 24720683 [TBL] [Abstract][Full Text] [Related]
14. Regulator of G-protein signaling Gβ5-R7 is a crucial activator of muscarinic M3 receptor-stimulated insulin secretion. Wang Q; Pronin AN; Levay K; Almaca J; Fornoni A; Caicedo A; Slepak VZ FASEB J; 2017 Nov; 31(11):4734-4744. PubMed ID: 28687610 [TBL] [Abstract][Full Text] [Related]
15. Ringing the dinner bell for insulin: muscarinic M3 receptor activity in the control of pancreatic beta cell function. Gromada J; Hughes TE Cell Metab; 2006 Jun; 3(6):390-2. PubMed ID: 16753574 [TBL] [Abstract][Full Text] [Related]
16. Random mutagenesis of the M3 muscarinic acetylcholine receptor expressed in yeast. Identification of point mutations that "silence" a constitutively active mutant M3 receptor and greatly impair receptor/G protein coupling. Schmidt C; Li B; Bloodworth L; Erlenbach I; Zeng FY; Wess J J Biol Chem; 2003 Aug; 278(32):30248-60. PubMed ID: 12750375 [TBL] [Abstract][Full Text] [Related]
17. Metabolic roles of the M3 muscarinic acetylcholine receptor studied with M3 receptor mutant mice: a review. Gautam D; Jeon J; Li JH; Han SJ; Hamdan FF; Cui Y; Lu H; Deng C; Gavrilova O; Wess J J Recept Signal Transduct Res; 2008; 28(1-2):93-108. PubMed ID: 18437633 [TBL] [Abstract][Full Text] [Related]
18. Increased insulin secretion by muscarinic M1 and M3 receptor function from rat pancreatic islets in vitro. Renuka TR; Robinson R; Paulose CS Neurochem Res; 2006 Mar; 31(3):313-20. PubMed ID: 16733808 [TBL] [Abstract][Full Text] [Related]
19. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans. Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901 [TBL] [Abstract][Full Text] [Related]
20. M3-muscarinic receptor promotes insulin release via receptor phosphorylation/arrestin-dependent activation of protein kinase D1. Kong KC; Butcher AJ; McWilliams P; Jones D; Wess J; Hamdan FF; Werry T; Rosethorne EM; Charlton SJ; Munson SE; Cragg HA; Smart AD; Tobin AB Proc Natl Acad Sci U S A; 2010 Dec; 107(49):21181-6. PubMed ID: 21078968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]